ea0016p445 | Neuroendocrinology | ECE2008
Kars Marleen
, Delgado Victoria
, Holman Eduard
, Feelders Richard
, Smit Jan
, Romijn Hans
, Bax Jeroen
, Pereira Alberto
Objective: Treatment with ergot-derived dopamine agonists, pergolide and cabergoline, has been associated with an increased frequency of valvular heart disease in Parkinsons disease. The aim of the present study was to assess the prevalence of valvular heart disease in patients treated with dopamine agonists for prolactinomas.Design: Cross-sectional study.Patients: We performed conventional two-dimensional and Doppler echocar...